Seaman Paper Company is pleased to announce the acquisition of South Windsor, Connecticut-based Eagle Tissue LLC, a provider of tissue paper printing and converting services. “We believe this acquisition will greatly improve the service and production capabilities of both Seaman and Eagle, and we expect our customers to benefit from this enhancement,” said Ken Winterhalter, CEO of Seaman Paper. “Importantly, the team at Eagle Tissue shares our passion for people and the planet, and their hard work and dedication to customer relationships align perfectly with our core values at Seaman Paper.” “We are excited to join such an incredible team of like-minded people. We have grown our business and partnerships over the last 26 years, and I believe this is the perfect next step for Eagle,” added Bob Costa, CEO of Eagle Tissue.

Ahlstrom-Munksjö's sterile barrier systems offer excellent bacterial barrier thanks to cellulosic fibers that create a tortuous path for excellent sterility maintenance of surgical instruments up to the point of use. Thanks to their features, our high-performance sterilization wraps play a key role in the prevention of hospital-acquired infections, protecting patients’ health. Dextex wetlaid sterilization wraps have a long history of use in the sterilization industry and are well recognized throughout the globe for their reliable performance. In our continuous effort to facilitate our customers and help their businesses succeed, we have decided to harmonize the wetlaid portfolio of high performance sterilization wraps in the United States under our globally recognized Reliance® brand.

Appvion, Inc. announced that it and certain of its subsidiaries filed voluntary petitions for relief under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware to facilitate a balance sheet restructuring and better position the business for long-term growth and success. The Company expects to continue operations as usual and has obtained a commitment for $85 million in new debtor-in-possession ("DIP") financing from a group of its first lien lenders. Subject to Bankruptcy Court approval, this DIP financing, combined with cash generated by the Company, is expected to provide more than adequate liquidity to support ongoing operations during the process. "We thoroughly explored various alternatives to address our debt and have been engaged in constructive discussions with our lenders regarding sponsorship of a plan to delever the Company and enhance our liquidity," said Kevin Gilligan, Chief Executive Officer of Appvion. "While those discussions are active and continuing, we determined that pursuing a restructuring through Chapter 11 is the best path forward for Appvion and our stakeholders. We believe this process will result in a sustainable capital structure for our business." Click Read More below for additional detail.